Cena / účetní hodnota společnosti Aerie Pharmaceuticals Inc
Jaká je hodnota metriky Cena / účetní hodnota společnosti Aerie Pharmaceuticals Inc?
Hodnota metriky Cena / účetní hodnota společnosti Aerie Pharmaceuticals Inc je -43.48
Jaká je definice metriky Cena / účetní hodnota?
Cena / učetní hodnota (Price to book ratio) je ukazatel, který vyjadřuje poměr mezi hodnotou společnosti a book value společnosti, což je hodnota čistých aktiv.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Cena / účetní hodnota společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Aerie Pharmaceuticals Inc
Čemu se věnuje společnost Aerie Pharmaceuticals Inc?
Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases. Aerie's first product, Rhopressa® (netarsudil ophthalmic solution) 0.02%, a once-daily eye drop approved by the U.S. Food and Drug Administration (FDA) for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension, was launched in the United States in April 2018. In clinical trials of Rhopressa®, the most common adverse reactions were conjunctival hyperemia, corneal verticillata, instillation site pain, and conjunctival hemorrhage. Aerie's second product for the reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension, Rocklatan® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%, the first and only fixed-dose combination of Rhopressa® and the widely-prescribed PGA (prostaglandin analog) latanoprost, was launched in the United States in May 2019. In clinical trials of Rocklatan®, the most common adverse reactions were conjunctival hyperemia, corneal verticillata, instillation site pain, and conjunctival hemorrhage. Aerie continues to focus on global expansion and the development of additional product candidates and technologies in ophthalmology, including for wet age-related macular degeneration and diabetic macular edema.
Firmy s metrikou cena / účetní hodnota podobnou společnosti Aerie Pharmaceuticals Inc
- Hodnota metriky Cena / účetní hodnota společnosti Enservco Corp je -45.00
- Hodnota metriky Cena / účetní hodnota společnosti Rosetta Stone je -44.54
- Hodnota metriky Cena / účetní hodnota společnosti John Menzies Plc je -44.47
- Hodnota metriky Cena / účetní hodnota společnosti Tata Communications je -44.44
- Hodnota metriky Cena / účetní hodnota společnosti CMC Metals je -44.14
- Hodnota metriky Cena / účetní hodnota společnosti Mega Copper je -44.03
- Hodnota metriky Cena / účetní hodnota společnosti Aerie Pharmaceuticals Inc je -43.48
- Hodnota metriky Cena / účetní hodnota společnosti BioForce Nanosciences je -43.43
- Hodnota metriky Cena / účetní hodnota společnosti Motive Capital Corp II je -43.08
- Hodnota metriky Cena / účetní hodnota společnosti Wintac je -42.88
- Hodnota metriky Cena / účetní hodnota společnosti Cascadero Copper je -42.88
- Hodnota metriky Cena / účetní hodnota společnosti McDonald`s Corp je -42.72
- Hodnota metriky Cena / účetní hodnota společnosti TAKE Solutions je -42.51